 Home > Active Ingredient News > Blood System > Support Care Cancer: Thrombosis and catheter-related bloodstream infections are significant complications of CVC in AML patients

Support Care Cancer: Thrombosis and catheter-related bloodstream infections are significant complications of CVC in AML patients

 Last Update: 2022-02-18
 Source: Internet
 Author: User

Tags

cd 1 2

patient drape

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Central venous catheters (CVCs) are widely used in patients with acute myeloid leukemia (AML)
.
Complications associated with CVC are frequently encountered and contribute to morbidity and mortality
.
Prospective studies investigating and comparing different types of CVC complications in AML patients and their impact on quality of life are limited
.
A research team conducted a prospective observational study to assess complications associated with CVC use during induction chemotherapy in adult AML patients and to assess patient-reported quality of life outcomes during and after hospitalization

Central venous catheters (CVCs) are widely used in patients with acute myeloid leukemia (AML)

Figure 1: Patient-reported experiences and activities related to CVC
.
Mean scores on questionnaires administered to patients 2 weeks after CVC placement and 90 days after discharge
.
Results were compared with the Wilcoxon rank sum test
.
TCC, tunneled central catheter; PICC, peripherally inserted central catheter
.

Table 1: Characteristics of patients

Table 2: Complications associated with CVC in AML patients The results show that 50 newly diagnosed AML patients (median age, 59 years) receiving intensive induction chemotherapy were included in the study

.
A peripherally inserted central catheter (PICC) was placed in 29 patients (58%) and a Hickmann tunneled central catheter (TCC) was placed in 21 (42%) patients

Table 2: CVC-related complications in AML patients Fifty newly diagnosed AML patients (median age, 59 years) receiving intensive induction chemotherapy were included in the study .
A peripherally inserted central catheter (PICC) was placed in 29 patients (58%) and a Hickmann tunneled central catheter (TCC) was placed in 21 (42%) patients .
Catheter-related thrombosis occurred in 3% of cases in PICC but not in TCC .

Original source:

McKeown, C.

, Ricciuti, A.
, Agha, M.

McKeown, C.
, Ricciuti, A.
, Agha, M.
et al.
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
Support Care Cancer 30, 1673–1679 (2022 ).
https://doi.
org/10.
1007/s00520-021-06339-x McKeown, C.
, Ricciuti, A.
, Agha, M.
et al.
A prospective study of the use of central venous catheters in patients newly diagnosed with acute myeloid leukemia treated with induction chemotherapy.
Support Care Cancer 30, 1673–1679 (2022).
https://doi.
org/10.
1007/s00520-021-06339-x Leave a comment here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.